Adam Blumenthal ordered to pay $850,000 and disqualified for five years for market rigging and directors’ duties breaches
The Federal Court has ordered Adam Blumenthal, former director of EverBlu Capital Pty Ltd (EverBlu) and Creso Pharma Limited (now known as Melodiol Global Health Limited) (Creso), to pay a penalty of $850,000 and be disqualified from managing corporations for five years following action brought by ASIC. On 17 April 2024, the Court found Mr …